ATC code L04

This MedLibrary.org supplementary page on ATC code L04 is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:

Related Sponsors

BM Pharmacy Generic pharmaceuticals at unbeatable prices. Insomnia, men's health, hair health, pain control. bmpharmacy.com
Online Pharmacy Carisoprodol, tadalafil, sildenafil, vardenafil and more... xlpharmacy.com
MedBasket.com Discreet. Inexpensive. Fast shipping. Great selection. What more can we say? medbasket.com
Frugalmed 2000 reasons to shop with us first. frugalmed.com
Ads by Tiva

A section of the Anatomical Therapeutic Chemical Classification System.

L Antineoplastic and immunomodulating agents

L04A Immunosuppressive agents

L04AA Selective immunosuppressive agents

L04AA01 Ciclosporin
L04AA02 Muromonab-CD3
L04AA03 Antilymphocyte immunoglobulin (horse)
L04AA04 Antithymocyte immunoglobulin (rabbit)
L04AA05 Tacrolimus
L04AA06 Mycophenolic acid
L04AA08 Daclizumab
L04AA09 Basiliximab
L04AA10 Sirolimus
L04AA11 Etanercept
L04AA12 Infliximab
L04AA13 Leflunomide
L04AA14 Anakinra
L04AA15 Alefacept
L04AA16 Afelimomab
L04AA17 Adalimumab
L04AA18 Everolimus
L04AA19 Gusperimus
L04AA21 Efalizumab
L04AA22 Abetimus
L04AA23 Natalizumab

L04AX Other immunosuppressive agents

L04AX01 Azathioprine
L04AX02 Thalidomide
L04AX03 Methotrexate
v • d • e
Immunomodulators - Immunosuppressants - Immunosuppressive drugs (L04)
Extracellular
CD3 (Muromonab-CD3, Teplizumab, Visilizumab) · CD4 (Keliximab, Zanolimumab) · CD11a (Efalizumab) · CD20 (Ocrelizumab, Pascolizumab) · CD23 (Lumiliximab) · IL-2/CD25 (Basiliximab, Daclizumab, Inolimomab) · CD40 (Teneliximab) · CD62L/L-selectin (Aselizumab) · CD147/Basigin (Gavilimomab, Ziralimumab) · CD154 (Ruplizumab)

BLyS (Belimumab)  · Complement component 5 (Eculizumab) · CTLA-4 (Ipilimumab) · CAT (Metelimumab) · Immunoglobulin E (Omalizumab) · Integrin (Natalizumab) · Interleukin 5 (Mepolizumab) · Interleukin-6 receptor (Tocilizumab) · TNFs (Infliximab, Adalimumab, Certolizumab pegol, Afelimomab, Golimumab) · LFA-1 (Odulimomab)

other monoclonal: Atlizumab, Atorolimumab, Bertilimumab, Cedelizumab, Clenoliximab, Dorlimomab aritox, Dorlixizumab, Elsilimomab, Erlizumab, Faralimomab, Fontolizumab, Galiximab, Gantenerumab, Gomiliximab, Ibalizumab, Lebrilizumab, Lerdelimumab, Maslimomab, Morolimumab, Nerelimomab, Otelixizumab, Pexelizumab, Reslizumab, Rovelizumab, Siplizumab, Talizumab, Telimomab aritox, Toralizumab, Ustekinumab, Vapaliximab, Vepalimomab, Zolimomab aritox

Polyclonal: Anti-thymocyte globulin
Intracellular
Macrolides/
other IL-2 inhibitors
TNF-α inhibitor

Wikipedia content modification information:

  • This page was last modified on 12 August 2008, at 17:08.

Wikipedia Authorship and Review

Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.

Wikipedia Usage Guidelines

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "ATC code L04".

The URL for this specific entry is:

All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.